Grifols, S.A Operating Income 2012-2020 | GRFS

Grifols, S.A annual/quarterly operating income history and growth rate from 2012 to 2020. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • Grifols, S.A operating income for the quarter ending June 30, 2020 was $M, a 100% decline year-over-year.
  • Grifols, S.A operating income for the twelve months ending June 30, 2020 was $0.668B, a 40.19% decline year-over-year.
  • Grifols, S.A annual operating income for 2019 was $1.267B, a 7.93% increase from 2018.
  • Grifols, S.A annual operating income for 2018 was $1.174B, a 3.53% increase from 2017.
  • Grifols, S.A annual operating income for 2017 was $1.134B, a 9.09% increase from 2016.
Grifols, S.A Annual Operating Income
(Millions of US $)
2019 $1,267
2018 $1,174
2017 $1,134
2016 $1,040
2015 $1,077
2014 $1,140
2013 $978
2012 $849
2011 $450
Grifols, S.A Quarterly Operating Income
(Millions of US $)
2020-06-30
2020-03-31
2019-06-30 $356
2018-06-30 $312
2017-06-30 $314
2017-03-31 $269
2016-12-31 $267
2016-09-30 $267
2016-06-30 $250
2016-03-31 $255
2015-12-31 $276
2015-09-30 $275
2015-06-30 $259
2015-03-31 $264
2014-12-31 $171
2014-09-30 $284
2014-06-30 $237
2014-03-31 $324
2013-12-31 $209
2013-09-30 $247
2013-06-30 $266
2013-03-31 $248
2012-12-31 $188
2012-09-30 $215
2012-06-30 $216
2012-03-31 $213
2011-12-31 $796
2011-09-30 $807
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $12.630B $5.711B
Grifols, S.A., operates in the pharmaceutical-hospital sector engaged in the research, development and retailing of plasma derivates, products for intravenous therapy, clinical nutrition, diagnostic and hospital logistics systems. The Company operates its business through three divisions: Bioscience Division, Diagnostic Division and Hospital Division. The Bioscience division is engaged in the research, development, production and commercialization of plasma derivates. Diagnostic Division focuses on researching, developing, manufacturing and marketing diagnostics products for laboratory analysis, including products for Hospital Blood Banks and Transfusion Centers. Hospital Division provides non-biological products used in hospital pharmacies, surgery, nutritional support, fluid therapy and for other therapeutic uses. Grifols, S.A. is based in Barcelona, Spain.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $75.486B 42.94
Takeda Pharmaceutical (TAK) Japan $58.483B 10.19
Astellas Pharma (ALPMY) Japan $30.589B 15.50
Eisai (ESALY) Japan $26.024B 21.99
UCB SA (UCBJF) Belgium $23.720B 0.00
Merck (MKGAF) Germany $17.609B 23.09
Catalent (CTLT) United States $13.694B 52.94
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.140B 0.00
Neurocrine Biosciences (NBIX) United States $10.700B 41.42
Ono Pharmaceutical (OPHLF) Japan $9.254B 16.36
Ionis Pharmaceuticals (IONS) United States $7.417B 46.98
Orion OYJ (ORINY) Finland $7.077B 24.56
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $7.052B 0.00
STADA ARZNEIMI (STDAF) Germany $6.858B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.828B 11.30
United Therapeutics (UTHR) United States $4.858B 11.23
Arrowhead Pharmaceuticals (ARWR) United States $4.369B 0.00
FibroGen (FGEN) United States $4.076B 0.00
Evotec AG (EVTCY) Germany $3.967B 137.87
Hypermarcas (HYPMY) Brazil $3.914B 14.40
ChemoCentryx (CCXI) United States $3.666B 0.00
Nektar Therapeutics (NKTR) United States $3.587B 0.00
PTC Therapeutics (PTCT) United States $3.351B 0.00
Sage Therapeutics (SAGE) United States $2.613B 0.00
Pacira BioSciences (PCRX) United States $2.594B 68.18
Taro Pharmaceutical Industries (TARO) Israel $2.414B 11.69
Cronos Group (CRON) Canada $2.008B 0.00
Xencor (XNCR) United States $1.910B 0.00
Revolution Medicines (RVMD) United States $1.796B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.786B 0.00
USANA Health Sciences (USNA) United States $1.759B 16.57
Ironwood Pharmaceuticals (IRWD) United States $1.630B 11.37
Indivior (INVVY) United States $1.606B 19.91
Corcept Therapeutics (CORT) United States $1.583B 14.57
Akebia Therapeutics (AKBA) United States $1.523B 0.00
Heron Therapeutics (HRTX) United States $1.439B 0.00
Zogenix (ZGNX) United States $1.376B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.280B 12.20
Karyopharm Therapeutics (KPTI) United States $1.114B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.102B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.075B 0.00
Translate Bio (TBIO) United States $1.069B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.995B 619.63
VAXART, INC (VXRT) United States $0.993B 0.00
Esperion Therapeutics (ESPR) United States $0.924B 0.00
Tilray (TLRY) Canada $0.880B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.812B 0.00
Altimmune (ALT) United States $0.780B 0.00
Trillium Therapeutics (TRIL) Canada $0.754B 0.00
Vectura Group (VEGPF) United Kingdom $0.737B 0.00
Endo (ENDP) Ireland $0.717B 1.06
ImmunoGen (IMGN) United States $0.669B 0.00
Collegium Pharmaceutical (COLL) United States $0.619B 0.00
Flexion Therapeutics (FLXN) United States $0.604B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.599B 0.00
Molecular Templates (MTEM) United States $0.590B 0.00
Aerie Pharmaceuticals (AERI) United States $0.576B 0.00
Siga Technologies (SIGA) United States $0.566B 60.42
Radius Health (RDUS) United States $0.562B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.551B 0.00
Ocular Therapeutix (OCUL) United States $0.508B 0.00
Ardelyx (ARDX) United States $0.507B 0.00
Innate Pharma SA (IPHYF) France $0.506B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.503B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.491B 24.47
DURECT (DRRX) United States $0.461B 0.00
Organogenesis Holdings (ORGO) United States $0.429B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.424B 0.00
TherapeuticsMD (TXMD) United States $0.422B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.353B 8.74
IMV INC (IMV) Canada $0.316B 0.00
Heat Biologics (HTBX) United States $0.312B 0.00
OptiNose (OPTN) United States $0.312B 0.00
Harpoon Therapeutics (HARP) United States $0.311B 0.00
MEI Pharma (MEIP) United States $0.305B 0.00
Concert Pharmaceuticals (CNCE) United States $0.302B 0.00
PROFOUND MEDICL (PROF) Canada $0.301B 0.00
Calithera Biosciences (CALA) United States $0.301B 0.00
Redhill Biopharma (RDHL) Israel $0.295B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.289B 0.00
Rafael Holdings (RFL) United States $0.281B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.266B 0.00
Lannett Co Inc (LCI) United States $0.249B 5.45
CASI Pharmaceuticals (CASI) United States $0.238B 0.00
Nivalis Therapeutics (ALPN) United States $0.223B 0.00
Aquestive Therapeutics (AQST) United States $0.223B 0.00
KalVista Pharmaceuticals (KALV) United States $0.222B 0.00
Nature's Sunshine Products (NATR) United States $0.220B 21.71
Taiwan Liposome (TLC) Taiwan $0.190B 0.00
Onconova Therapeutics (ONTX) United States $0.181B 0.00
Xeris Pharmaceuticals (XERS) United States $0.170B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.169B 0.00
Jounce Therapeutics (JNCE) United States $0.164B 7.77
Otonomy (OTIC) United States $0.163B 0.00
Lipocine (LPCN) United States $0.136B 0.00
Champions Oncology (CSBR) United States $0.120B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.112B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.111B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
India Globalization Capital (IGC) United States $0.105B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.102B 0.00
Hemispherx BioPharma (AIM) United States $0.101B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.101B 0.00
Biomerica (BMRA) United States $0.100B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.096B 0.00
MediWound (MDWD) Israel $0.094B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.093B 0.00
Aclaris Therapeutics (ACRS) United States $0.092B 0.00
CTI BioPharma (CTIC) United States $0.092B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.089B 0.00
ElectroCore (ECOR) United States $0.086B 0.00
Addex Therapeutics (ADXN) Switzerland $0.080B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.079B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.075B 0.00
Sundial Growers (SNDL) Canada $0.074B 0.00
Recro Pharma (REPH) United States $0.073B 0.00
SCYNEXIS (SCYX) United States $0.072B 0.00
Infinity Pharmaceuticals (INFI) United States $0.069B 0.00
CV Sciences (CVSI) United States $0.066B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.063B 0.00
PolarityTE (PTE) United States $0.057B 0.00
GTx (ONCT) United States $0.056B 0.00
RENEURON GP (RNUGF) United Kingdom $0.053B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.051B 30.73
Natural Alternatives (NAII) United States $0.048B 0.00
AgeX Therapeutics (AGE) United States $0.046B 0.00
IsoRay (ISR) United States $0.045B 0.00
Forward Pharma (FWP) Denmark $0.044B 0.00
Novan (NOVN) United States $0.044B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.042B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.039B 0.00
Mannatechorporated (MTEX) United States $0.036B 9.07
Bellicum Pharmaceuticals (BLCM) United States $0.035B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.034B 0.00
Can-Fite Biopharma (CANF) Israel $0.034B 0.00
Neos Therapeutics (NEOS) United States $0.033B 0.00
Jaguar Animal Health (JAGX) United States $0.033B 0.00
ProPhase Labs (PRPH) United States $0.032B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.026B 0.00
Vical (BBI) United States $0.023B 0.00
Bio-Path Holdings (BPTH) United States $0.020B 0.00
Iterum Therapeutics (ITRM) Ireland $0.019B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.015B 0.00
RXi Pharmaceuticals (PHIO) United States $0.014B 0.00
Cyanotech (CYAN) United States $0.014B 21.31
Flex Pharma (SLRX) United States $0.014B 0.00
Regulus Therapeutics (RGLS) United States $0.013B 0.00
Shineco (TYHT) China $0.013B 0.00
China SXT Pharmaceuticals (SXTC) China $0.013B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.012B 0.00
Midatech Pharma (MTP) United Kingdom $0.012B 0.00
HANCOCK JAFFE (HJLI) United States $0.012B 0.00
Xenetic Biosciences (XBIO) United States $0.008B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00